Biotech startup Cellivate Technologies raises $1-M led by Antler
Singapore-based biotech startup Cellivate Technologies has raised USD 1 million in a seed round led by Antler along with participation from Venture Catalysts, Hatcher+, and We Founder Circle. The funds will be used to accelerate its R&D efforts, scale up production of products, and expand its market reach.Launched by Viknish Krishnan Kutty, Cellivate is developing solutions to address challenges in cell culture and biomanufacturing. The company’s flagship products include advanced microcarriers for scaling up cell growth and a cell-based serum designed to replace foetal bovine serum.
Want to receive such news items in your inbox? Click Here to sign up for a trial.